1
Clinical Trials associated with BX002A Phase 1, Randomized, Single-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of Orally Administered BX002-A in Healthy Adult Individuals
The purpose of study BMX-02-001 is to evaluate the safety, tolerability and feasibility of orally administered BX002-A to deliver viable bacteriophages to the gut.
100 Clinical Results associated with BX002
100 Translational Medicine associated with BX002
100 Patents (Medical) associated with BX002
100 Deals associated with BX002